Infection Control News

According to this study, patients categorized as “non-Hispanic Black” and Hispanic who were on hemodialysis faced significantly greater risk for contracting COVID-19 during the first surge of cases in New York City.

One of the challenges health care providers face in administering COVID-19 vaccines is vaccine hesitancy, especially among disadvantaged populations.

The number of patients receiving treatment for end-stage kidney disease in April was 0.6% lower than a year ago, the first such year-to-year drop in patient census since 1980, a new study shows.

For patients receiving hemodialysis in the United States, prior infection with SARS-CoV-2 led to lower risks for subsequent reinfection and for the development of clinically manifest COVID-19.

AKI was more common in hospitalizations for COVID-19 than influenza, with study results indicating that AKI with the former led to more severe outcomes, including the need for mechanical ventilation and increased mortality.

Trends in COVID-19 prevalence and mortality were similar among patients on home dialysis and those on in-center dialysis, with changes throughout the pandemic mirroring that of the general population in the United States.

Patients with kidney failure who received the COVID-19 vaccine from Pfizer-BioNTech showed varying degrees of antibody and T-cell responses, with those on dialysis achieving greater protection from the vaccine than transplant recipients.

Transplanting organs from donors with hepatitis C virus may increase the number of transplants performed and reduce waitlist times, but the optimal treatment strategy for recipients requires further investigation, according to a speaker.

Excess mortality rates rose between February and August 2020 for the end-stage renal disease population, with patients on dialysis having two to three times higher total excess deaths compared with transplant recipients.

For patients hospitalized with COVID-19, a boosted decision tree model more accurately predicted AKI requiring dialysis and mortality compared with either standard models or other machine learning models.